Cargando…

Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice

Tauopathies are widespread neurodegenerative disorders characterised by the intracellular accumulation of hyperphosphorylated tau. Especially in Alzheimer's disease, pathological alterations in the retina are discussed as potential biomarkers to improve early diagnosis of the disease. Using mic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schön, Christian, Hoffmann, Nadine A., Ochs, Simon M., Burgold, Steffen, Filser, Severin, Steinbach, Sonja, Seeliger, Mathias W., Arzberger, Thomas, Goedert, Michel, Kretzschmar, Hans A., Schmidt, Boris, Herms, Jochen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534024/ https://www.ncbi.nlm.nih.gov/pubmed/23300938 http://dx.doi.org/10.1371/journal.pone.0053547

Ejemplares similares

Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice
por: Hoffmann, Nadine A, et al.
Publicado: (2013)

Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
por: Ozcelik, Sefika, et al.
Publicado: (2013)

In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques
por: Burgold, Steffen, et al.
Publicado: (2014)

Multiple Events Lead to Dendritic Spine Loss in Triple Transgenic Alzheimer's Disease Mice
por: Bittner, Tobias, et al.
Publicado: (2010)

Fibrillar Amyloid Plaque Formation Precedes Microglial Activation
por: Jung, Christian K. E., et al.
Publicado: (2015)

Tauopathy-induced retinal dysfunction in the P301S mutant human tau transgenic mouse
por: Mazzaro, Nadia, et al.
Publicado: (2013)

Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
por: Höllerhage, Matthias, et al.
Publicado: (2014)

Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord
por: Macdonald, Jennifer A., et al.
Publicado: (2019)

Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau
por: Schweighauser, Manuel, et al.
Publicado: (2023)

Label-free 3D-CLEM Using Endogenous Tissue Landmarks
por: Luckner, Manja, et al.
Publicado: (2018)

Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
por: Eckenweber, Florian, et al.
Publicado: (2020)

Reduced Axonal Transport and Increased Excitotoxic Retinal Ganglion Cell Degeneration in Mice Transgenic for Human Mutant P301S Tau
por: Bull, Natalie D., et al.
Publicado: (2012)

Immunotherapy alleviates amyloid-associated synaptic pathology in an Alzheimer’s disease mouse model
por: Dorostkar, Mario M., et al.
Publicado: (2014)

Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
por: Hosokawa, Masato, et al.
Publicado: (2012)

Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice
por: Ohia-Nwoko, Odochi, et al.
Publicado: (2014)

Correction: Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
Publicado: (2015)

Altered sleep and EEG power in the P301S Tau transgenic mouse model
por: Holth, Jerrah K., et al.
Publicado: (2017)

Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice
por: Zhong, Suyue, et al.
Publicado: (2023)

Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2020)

Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
por: Bi, Mian, et al.
Publicado: (2011)

Biochemical Distribution of Tau Protein in Synaptosomal Fraction of Transgenic Mice Expressing Human P301L Tau
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer’s disease
por: Zou, Chengyu, et al.
Publicado: (2015)

The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
por: Valencia, Antonio, et al.
Publicado: (2021)

Alteration in the Synaptic and Extrasynaptic Organization of AMPA Receptors in the Hippocampus of P301S Tau Transgenic Mice
por: Alfaro-Ruiz, Rocio, et al.
Publicado: (2022)

A30P α-Synuclein interferes with the stable integration of adult-born neurons into the olfactory network
por: Neuner, Johanna, et al.
Publicado: (2014)

Correction to: The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice
por: Kunze, Lea Helena, et al.
Publicado: (2023)

Antileukotriene therapy by reducing tau phosphorylation improves synaptic integrity and cognition of P301S transgenic mice
por: Giannopoulos, Phillip F., et al.
Publicado: (2018)

Contribution of endogenous antibodies to learning deficits and astrocytosis in human P301S mutant tau transgenic mice
por: van der Hoven, Julia, et al.
Publicado: (2020)

Different modes of synaptic and extrasynaptic NMDA receptor alteration in the hippocampus of P301S tau transgenic mice
por: Alfaro‐Ruiz, Rocío, et al.
Publicado: (2022)

Impact of α‐synuclein spreading on the nigrostriatal dopaminergic pathway depends on the onset of the pathology
por: Sun, Fanfan, et al.
Publicado: (2021)

The fluorescent pentameric oligothiophene pFTAA identifies filamentous tau in live neurons cultured from adult P301S tau mice
por: Brelstaff, Jack, et al.
Publicado: (2015)

Longitudinal evaluation of Tau‐P301L transgenic mice reveals no cognitive impairments at 17 months of age
por: Kent, Brianne A., et al.
Publicado: (2017)

Commentary: Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice
por: Betts, Matthew J., et al.
Publicado: (2018)

Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
por: Chang, Yanmin, et al.
Publicado: (2021)

The Change in Circadian Rhythms in P301S Transgenic Mice is Linked to Variability in Hsp70-related Tau Disaggregation
por: Han, Song Mi, et al.
Publicado: (2022)

Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
por: Mate De Gerando, Anastasie, et al.
Publicado: (2023)

Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer’s Disease Like Tau Aggregation
por: Richter, Monique, et al.
Publicado: (2014)

P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice
por: Ruan, Zhi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_unpnj4dvtortm7tm541ipih7jh